7827 results for "canc*"

in 23.25 milliseconds.

• Genome and transcriptome sequence data from a metastatic breast carcinoma patient

  Genome and transcriptome sequence data from a metastatic breast carcinoma patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study

  Dataset EGAD00001003042

• Genome and transcriptome sequence data from a breast carcinoma patient

  Genome and transcriptome sequence data from a breast carcinoma patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study

  Dataset EGAD00001003043

• Genome and transcriptome sequence data from a metastatic breast cancer patient

  Genome and transcriptome sequence data from a metastatic breast cancer patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study

  Dataset EGAD00001003044

• Genome and transcriptome sequence data from a metastatic lung cancer patient

  Genome and transcriptome sequence data from a metastatic lung cancer patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study

  Dataset EGAD00001003045

• Genome and transcriptome sequence data from a sigmoid cancer and an ampullary cancer patient

  Genome and transcriptome sequence data from a sigmoid cancer and an ampullary cancer patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study

  Dataset EGAD00001003046

• High Grade Serous Ovarian Cancer Whole Exome Sequencing

  Whole exome sequencing (WES) was performed on genomic DNA (50–200 ng) extracted from high-grade serous ovarian cancer (HGSOC) tumor tissue and matched buffy coat or normal tissue. DNA was sheared using a Covaris E220 system to generate fragments of approximately 150–200 bp. Sequencing libraries were prepared using the Agilent SureSelect XT Low Input Library Preparation Kit with unique dual indices. Tumor libraries were enriched using a custom SureSelect V6 + UTR + OneSeq LowRes capture probe set, while germline libraries were enriched using the Agilent SureSelect Human All Exon V6 capture kit supplemented with custom probes. Libraries underwent initial quality control sequencing on the Illumina MiSeq platform, followed by pooled sequencing on the Illumina NovaSeq 6000 using a 300-cycle kit. Archived here are the BAM files for each sample.

  Dataset EGAD50000002488

• Genome and transcriptome sequence data from a metastatic sigmoid colon cancer patient

  Genome and transcriptome sequence data from a metastatic sigmoid colon cancer patient,generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study

  Dataset EGAD00001016390

• Genome and transcriptome sequence data from a metastatic small cell lung cancer patient

  Genome and transcriptome sequence data from a metastatic small cell lung cancer patient,generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study

  Dataset EGAD00001016391

• Genome and transcriptome sequence data from a peritoneal mesothelioma, epithelioid type patient

  Genome and transcriptome sequence data from a peritoneal mesothelioma, epithelioid type patient,generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study

  Dataset EGAD00001016392

• Genome and transcriptome sequence data from a metastatic kras mutant colon cancer patient

  Genome and transcriptome sequence data from a metastatic kras mutant colon cancer patient,generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study

  Dataset EGAD00001016393

• Genome and transcriptome sequence data from a thoracic/ mediastinal paraganglioma patient

  Genome and transcriptome sequence data from a thoracic/ mediastinal paraganglioma patient,generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study

  Dataset EGAD00001016394

• Genome and transcriptome sequence data from a metastatic osteosarcoma (left radius primary, lungmetastasis patient

  Genome and transcriptome sequence data from a metastatic osteosarcoma (left radius primary, lungmetastasis patient,generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study

  Dataset EGAD00001016395

• Genome and transcriptome sequence data from a recurrent uterine tumor resembling ovarian sex cord tumor (utrosct) patient

  Genome and transcriptome sequence data from a recurrent uterine tumor resembling ovarian sex cord tumor (utrosct) patient,generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study

  Dataset EGAD00001016396

• Genome and transcriptome sequence data from a metastatic colorectal adenocarcinoma patient

  Genome and transcriptome sequence data from a metastatic colorectal adenocarcinoma patient,generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study

  Dataset EGAD00001016397

• Genome and transcriptome sequence data from a metastatic sigmoid colon cancer patient

  Genome and transcriptome sequence data from a metastatic sigmoid colon cancer patient,generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study

  Dataset EGAD00001016398

• Genome and transcriptome sequence data from a triple negative breast cancer (ductal) patient

  Genome and transcriptome sequence data from a triple negative breast cancer (ductal) patient,generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study

  Dataset EGAD00001016399

• Genome and transcriptome sequence data from a metastatic adenoid cystic carcinoma of the right parotid gland to lymph nodes, lungs and bone patient

  Genome and transcriptome sequence data from a metastatic adenoid cystic carcinoma of the right parotid gland to lymph nodes, lungs and bone patient,generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study

  Dataset EGAD00001016400

• Genome and transcriptome sequence data from a metastatic clear cell sarcoma patient

  Genome and transcriptome sequence data from a metastatic clear cell sarcoma patient,generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study

  Dataset EGAD00001016401

• Genome and transcriptome sequence data from a braf wild-type malignant melanoma with cns metastasis patient

  Genome and transcriptome sequence data from a braf wild-type malignant melanoma with cns metastasis patient,generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study

  Dataset EGAD00001016402

• Genome and transcriptome sequence data from a locally advanced non small cell lung cancer patient

  Genome and transcriptome sequence data from a locally advanced non small cell lung cancer patient,generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study

  Dataset EGAD00001016403

• Genome and transcriptome sequence data from a metastatic periampullary carcinoma patient

  Genome and transcriptome sequence data from a metastatic periampullary carcinoma patient,generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study

  Dataset EGAD00001016404

• Genome and transcriptome sequence data from a metastatic breast cancer (ductal) patient

  Genome and transcriptome sequence data from a metastatic breast cancer (ductal) patient,generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study

  Dataset EGAD00001016405

• Genome and transcriptome sequence data from a metastatic gastric cancer patient

  Genome and transcriptome sequence data from a metastatic gastric cancer patient,generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study

  Dataset EGAD00001016406

• Genome and transcriptome sequence data from a metastatic distal esophageal adenocarcinoma with nodal and liver metastasis patient

  Genome and transcriptome sequence data from a metastatic distal esophageal adenocarcinoma with nodal and liver metastasis patient,generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study

  Dataset EGAD00001016407

• Genome and transcriptome sequence data from a metastatic breast ca to liver, er+, her2 low (ductal) patient

  Genome and transcriptome sequence data from a metastatic breast ca to liver, er+, her2 low (ductal) patient,generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study

  Dataset EGAD00001016408